Bussolati and colleagues recently showed that clones of CD105 + tumor/progenitor cells from human renal carcinomas can maintain hemostasis and differentiate into tumor endothelium and epithelium, both in vitro and in vivo8,10. Here, ENG is linked to neoplasm.